T.P.45 An ongoing phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha glucosidase in subjects with Pompe disease – Preliminary results

• 期刊名称Neuromuscular Disorders
• 作者Kishnani, P.; Tarnopolsky, M.; Sivakumar, K.; Byrne, B.; Goker-Alpan, O.; Guter, K.; Pervaiz, M.; Dasouki, M.; Levine, T.; Roberts, M.; Johnson, F.K.; Sitaraman, S.; Khanna, R.; Flanagan, J.; Sjoberg, E.R.; Valenzano, K.J.; Lockhart, D.J.; Boudes, P.
• 卷第22卷
• 印刷ISSN0960-8966
• 文件大小48.58KB
• 发表时间2012-10
• DOI10.1016/j.nmd.2012.06.164